Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 20 tags : Treatment save search
Immunome Announces Submission for Publication of Pre-clinical Research Detailing the Importance of Antibody Cocktail for SARS-CoV-2 Treatment and Prophylaxis
Published: 2021-10-20 (Crawled : 20:00) - biospace.com/
IMNM | $15.5 -9.78% -10.84% 2.1M
|
Health Technology
|
| O: 0.44%
H: 3.77%
C: 1.09%
treatment pre-clinical antibody research submission preclinical sars-cov-2
BeiGene and Nanolek Announce Approval in Russia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma
Published: 2021-10-20 (Crawled : 20:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.37%
H: 0.65%
C: -0.3%
treatment russia brukinsa approval
electroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England
Published: 2021-10-20 (Crawled : 14:00) - globenewswire.com
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: -0.99%
H: 1.0%
C: -0.5%
treatment
BeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherapy at the AACR-NCI-EORTC Virtual International Conference to Further Support the Positive Clinical Data Already Reported for the Treatment of Small Cell Lung Cancer
Published: 2021-10-20 (Crawled : 14:00) - beyondspringpharma.com
BYSI | $1.8 -2.21% 80K
|
Health Technology
|
| O: 0.96%
H: 6.9%
C: -0.42%
treatment lung cancer positive therapy cancer conference plinabulin
BeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherpy at the AACR-NCI-EORTC Virtual International Conference to Further Support the Positive Clinical Data Already Reported for the Treatment of Small Cell Lung Cancer
Published: 2021-10-20 (Crawled : 12:00) - beyondspringpharma.com
BYSI | $1.8 -2.21% 80K
|
Health Technology
|
| O: 0.96%
H: 6.9%
C: -0.42%
treatment lung cancer positive cancer conference plinabulin
Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Published: 2021-10-20 (Crawled : 10:00) - biospace.com/
RCKT M | $22.82 -2.81% -2.89% 960K
|
Health Technology
|
| O: 6.15%
H: 1.44%
C: -2.95%
treatment europe positive therapy trial
ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix for the Treatment of Uterine Fibroids at ASRM 2021 Scientific Congress & Expo
Published: 2021-10-20 (Crawled : 09:00) - globenewswire.com
OBSV | $0.1018 -15.52% -18.95% 8.2M
|
Health Technology
|
| O: 0.0%
H: 0.32%
C: -1.82%
treatment uterine fibroids linzagolix
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.